Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2016, Article ID 6580215, 4 pages
http://dx.doi.org/10.1155/2016/6580215
Case Report

Pseudopheochromocytoma Associated with Domestic Assault

1Department of General Internal Medicine, Centres Hospitaliers Jolimont, Nivelles, Belgium
2Intensive Care Unit, Centres Hospitaliers Jolimont, Nivelles, Belgium

Received 6 July 2016; Accepted 28 August 2016

Academic Editor: Nurten Sayar

Copyright © 2016 H. M. Le et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Kuchel, “Pseudopheochromocytoma,” Hypertension, vol. 7, no. 1, pp. 151–158, 1985. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Mann, “Severe paroxysmal hypertension (Pseudopheochromocytoma): understanding the cause and treatment,” Archives of Internal Medicine, vol. 159, no. 7, pp. 670–674, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Garcha and D. L. Cohen, “Catecholamine excess: pseudopheochromocytoma and beyond,” Advances in Chronic Kidney Disease, vol. 22, no. 3, pp. 218–223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. Mann, “Severe paroxysmal hypertension (pseudopheochromocytoma),” Current Hypertension Reports, vol. 10, no. 1, pp. 12–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Seck, E. F. Ka, A. Niang, and B. Diouf, “Pseudopheochromocytoma: an uncommon cause of malignant hypertension,” Indian Journal of Nephrology, vol. 19, no. 3, pp. 122–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. K. Cheezum and C. J. Lettieri, “Obstructive sleep apnea presenting as pseudopheochromocytoma,” Journal of Clinical Sleep Medicine, vol. 6, no. 2, pp. 190–191, 2010. View at Google Scholar · View at Scopus
  7. A. Páll, G. Becs, A. Erdei et al., “Pseudopheochromocytoma induced by anxiolytic withdrawal,” European Journal of Medical Research, vol. 19, pp. 53–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Suh, C. Quinn, and A. Rehwinkel, “Lateralizing sensorimotor deficits in a case of pseudopheochromocytoma,” Yale Journal of Biology and Medicine, vol. 87, no. 4, pp. 569–573, 2014. View at Google Scholar · View at Scopus
  9. Y. Sharabi, D. S. Goldstein, O. Bentho et al., “Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma,” Journal of Hypertension, vol. 25, no. 11, pp. 2286–2295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hamada, Y. Shigematsu, M. Mukai, Y. Kazatani, T. Kokubu, and K. Hiwada, “Blood pressure response to the valsalva maneuver in pheochromocytoma and pseudopheochromocytoma,” Hypertension, vol. 25, no. 2, pp. 266–271, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. McNeil, A. E. Anderson, W. J. Louis, and D. J. Morgan, “Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects,” British Journal of Clinical Pharmacology, vol. 8, no. 2, pp. 157S–161S, 1979. View at Publisher · View at Google Scholar
  12. S. Yilmaz, M. Pekdemir, Ü. Tural, and M. Uygun, “Comparison of alprazolam versus captopril in high blood pressure: a randomized controlled trial,” Blood Pressure, vol. 20, no. 4, pp. 239–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Linden and J. V. Moseley, “The efficacy of behavioral treatments for hypertension,” Applied Psychophysiology Biofeedback, vol. 31, no. 1, pp. 51–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Wexler and G. Aukerman, “Nonpharmacologic strategies for managing hypertension,” American Family Physician, vol. 73, no. 11, pp. 1953–1958, 2006. View at Google Scholar · View at Scopus
  15. R. H. Schneider, F. Staggers, C. N. Alexander et al., “A randomized controlled trial of stress reduction for hypertension in older African Americans,” Hypertension, vol. 26, no. 5, pp. 820–827, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. R. H. Schneider, C. N. Alexander, F. Staggers et al., “Long-term effects of stress reduction on mortality in persons ≥55 years of age with systemic hypertension,” American Journal of Cardiology, vol. 95, no. 9, pp. 1060–1064, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. X. F. Teng, M. Y. Wong, and Y. T. Zhang, “The effect of music on hypertensive patients,” in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society, pp. 4649–4651, 2007.
  18. A. Y. R. Kühlmann, J. R. G. Etnel, J. W. Roos-Hesselink, J. Jeekel, A. J. J. C. Bogers, and J. J. M. Takkenberg, “Systematic review and meta-analysis of music interventions in hypertension treatment: a quest for answers,” BMC Cardiovascular Disorders, vol. 16, no. 1, article 69, 2016. View at Publisher · View at Google Scholar